1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN

Repligen Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...

Read More
171.02 -0.16 (-0.09%)
66.10% Gain from 52W Low
388.2K
XNAS Volume

XNAS 28 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Repligen Corp is on 03 Dec 2025 for the purpose of 8(th) Annual Evercore Healthcare Conference See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
27.0 / 100
Momentum Score
Technically Moderately Bullish
68.9 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
187
1Yr Price target upside is 9%
18 analysts

18

S

16

W

3

O

1

T

SWOT Analysis

Repligen Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..